Concepedia

Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

Patrick M. Moriarty, Paul D. Thompson, Christopher P. Cannon, John R. Guyton, Jean Bergeron, Franklin J. Zieve, Éric Bruckert, Terry A. Jacobson, Stephen L. Kopecky, Marie T. Baccara‐Dinet,

Journal of clinical lipidology · 2015 · 467 citations · 25 references

DOIFull text

Open access

Concepts

References

25

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Neil J. Stone, Jennifer G. Robinson, Alice H. Lichtenstein et al. · Circulation · 2013 · 7.1K citations · Full text

, , +15

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Željko Reiner, Alberico L. Catapano, Guy De Backer et al. · European Heart Journal · 2011 · 3.5K citations · Full text

, , +17

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Jennifer G. Robinson, Michel Farnier, Michel Krempf et al. · New England Journal of Medicine · 2015 · 2.3K citations · Full text

, , +17

The Prevention and Treatment of Missing Data in Clinical Trials

Roderick J. A. Little, Ralph B. D’Agostino, Michael L. Cohen et al. · New England Journal of Medicine · 2012 · 1.9K citations · Full text

, , +15

Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study

Éric Bruckert, Gilles Hayem, S. Dejager et al. · Cardiovascular Drugs and Therapy · 2005 · 1.2K citations

, , +7